Treatment optimization of angiotensin converting enzyme inhibitors and associated factors in Ayder Comprehensive Specialized Hospital: a cross-sectional study

BACKGROUND: Angiotensin-converting enzyme inhibitors have morbidity and mortality benefits in heart failure. Failure to optimize treatment using these medications increases hospitalizations, worsens signs and symptoms of heart failure, and reduces the overall treatment outcome. Therefore, the main p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Res Notes
Autors principals: Atey, Tesfay Mehari, Teklay, Tsegay, Asgedom, Solomon Weldegebreal, Mezgebe, Haftay Berhane, Teklay, Gebrehiwot, Kahssay, Molla
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875017/
https://ncbi.nlm.nih.gov/pubmed/29592815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2820-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars